Stereotaxis (STXS) Reports Q2 Loss of $0.12/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. BTGO
6. NVDA
7. WYFI
8. STUB
9. EAT
10. BIRK

Go back to Stereotaxis (STXS) Reports Q2 Loss of $0.12/Share

Stereotaxis Reports 2015 Second Quarter Financial Results

August 4, 2015 6:30 AM EDT

- Total Revenue Increased 20% over Prior Year Second Quarter and 17% Year to Date - - Quarterly Operating Loss Decreased 25% Year over Year and 31% for the First Six Months Period - - First Niobe® ES Procedures Performed in Japan - - New Evidence of Clinical Advantages in Ventricular Tachycardia Shared at Industry Events - - Conference Call Today at 8:30 a.m. Eastern Time -

ST. LOUIS, Aug. 4, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ: STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today... More

Stereotaxis Reports 2015 Second Quarter Financial Results

August 4, 2015 6:30 AM EDT

- Total Revenue Increased 20% over Prior Year Second Quarter and 17% Year to Date - - Quarterly Operating Loss Decreased 25% Year over Year and 31% for the First Six Months Period - - First Niobe® ES Procedures Performed in Japan - - New Evidence of Clinical Advantages in Ventricular Tachycardia Shared at Industry Events - - Conference Call Today at 8:30 a.m. Eastern Time -

ST. LOUIS, Aug. 4, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ: STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today... More